Cargando...
Transcriptomic heterogeneity in multifocal prostate cancer
BACKGROUND. Commercial gene expression assays are guiding clinical decision making in patients with prostate cancer, particularly when considering active surveillance. Given heterogeneity and multifocality of primary prostate cancer, such assays should ideally be robust to the coexistence of unsampl...
Guardado en:
| Publicado en: | JCI Insight |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6238741/ https://ncbi.nlm.nih.gov/pubmed/30385730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.123468 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|